RETRACTED ARTICLE: The impact of letrozole on oocyte quality in assisted reproductive technology (ART); a randomized double-blind clinical trial

Batool Hossein Rashidi, Ensieh Shahrokh Tehraninejad, Saeed Amanpour, Fatemeh Bandarian, Mahin Bandarian

Open source

DOI
10.1080/09513590.2022.2160869
Published
2022-12-02
Container
Gynecological Endocrinology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/09513590.2022.2160869,
  title = {RETRACTED ARTICLE: The impact of letrozole on oocyte quality in assisted reproductive technology (ART); a randomized double-blind clinical trial},
  author = {Batool Hossein Rashidi and Ensieh Shahrokh Tehraninejad and Saeed Amanpour and Fatemeh Bandarian and Mahin Bandarian},
  year = {2022},
  journal = {Gynecological Endocrinology},
  doi = {10.1080/09513590.2022.2160869},
  url = {https://doi.org/10.1080/09513590.2022.2160869}
}

RIS

TY  - JOUR
TI  - RETRACTED ARTICLE: The impact of letrozole on oocyte quality in assisted reproductive technology (ART); a randomized double-blind clinical trial
AU  - Batool Hossein Rashidi
AU  - Ensieh Shahrokh Tehraninejad
AU  - Saeed Amanpour
AU  - Fatemeh Bandarian
AU  - Mahin Bandarian
PY  - 2022
JO  - Gynecological Endocrinology
DO  - 10.1080/09513590.2022.2160869
UR  - https://doi.org/10.1080/09513590.2022.2160869
ER  - 

APA

Rashidi, B. H., Tehraninejad, E. S., Amanpour, S., Bandarian, F., & Bandarian, M. (2022). RETRACTED ARTICLE: The impact of letrozole on oocyte quality in assisted reproductive technology (ART); a randomized double-blind clinical trial. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2022.2160869

Source records